3 min reading time
With the end of the calendar year upon us, you’ll be seeing top 10 lists for the year. And while I have two links to share with you, I’m more interested to learn which innovations and medtech startups made the most impact for you this year? Perhaps it’s something your company launched or improved. Maybe it’s something you worked on with a client or read about. This discussion is your opportunity to let our medical device community learn more about it. +++ At http://bit.ly/11-inno, Medical Design & Outsourcing lists the nominees for the best medical technology of 2017. They include: 2. Allergan’s Juvederm Vorbella XC, a lip filler. 3. Boston Scientific’s SpyGlass DS direct visualization system, used to examine bile ducts. 4. Boston Scientific’s Watchman left atrial appendage closure device, intended to help reduce stroke risk in some AFib patients. 5. The BrainScope One, an FDA-cleared head injury assessment device. 6. Insightec’s Exablate Neuro, an ultrasound device to treat medication refractory essential tremor patients using thalamotomy. 7. Integra LifeSciences’ Omnigraft dermal regeneration matrix for treating diabetic foot ulcers. 8. JNJ / DePuy Synthes’ Attune knee reconstruction system. 9. JNJ / Ethicon’s Evarrest fibrin sealant patch for general hemostasis. 10. Koning’s Breast CT 1000, which takes 3D images with spatial resolution; without compression. 11. Biosense Webster’s Thermocool SmartTouch SF catheter, designed to cool at half the flow rate of other irrigated catheters. Also see http://bit.ly/10-starts, MDO’s choices for the most interesting medical device startups of the year. +++ Happy Holidays to you,. Joe Hage P.S. The 10x price in 2018 is half the 2017 rate. If you have use-or-lose dollars, go ahead and register before year-end at https://medgroup.biz/10x. Joe Hage Julie Omohundro The main impact these things have for me these days is on my efforts to figure out what is going on with this industry. The startups that have had the most impact on me in recent years are those that have been touted as successful in the media by one measure or another, when I knew that the underlying reality was rather different. I will be interested to see how these devices look in another 5-10 years. Aaron R. Peterson Tom KraMer Paul M. Stein Danielle Boyd Kirk Zeller, DBA Hui Kuun Teoh Andy Pilling Alex Hatebur François Lellouche Marked as spam
|